News
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces that its prostate cancer PET[1] ...
18d
Bucks Free Press on MSNWycombe fan and former parish councillor to take part in charity walkA Hazlemere resident and Wycombe Wanderers fan will be taking part in a charity walk to raise much-needed funds and awareness for Prostate Cancer UK.
First Study to Confirm Safety of Stabilized Hyaluronic Acid (sHA) Rectal Spacer in Cases with Rectal Wall Infiltration (RWI).4 ...
ZERO Prostate Cancer is alarmed by the President's Fiscal Year 2026 Budget, which proposes sweeping cuts that would ...
1d
News-Medical.Net on MSNResearchers identify gene driving aggressive prostate cancerResearchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer ...
4d
News-Medical.Net on MSNNew AI test identifies prostate cancer patients who benefit from abirateroneA new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending ...
A study led by Cancer Center at Illinois (CCIL) member Jason Ridlon, associate professor of animal sciences in the College of ...
According to J&J, Akeega is the first PARP inhibitor combination that’s proven effective treating earlier-stage prostate ...
A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending ...
Researchers have identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly targeted with an ...
12don MSNOpinion
Developing tests that better identify patients at risk of dying from prostate cancer can decrease overtreatment. In the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results